PulmoTech
PulmoTech BV develops the CE-marked Intelligent Esophageal Pressure Catheter, a single device that combines in-situ esophageal pressure measurement with nasogastric feeding for adult ICU patients on mechanical ventilation. The Netherlands-based startup was acquired by Sentec in March 2025.
- Company typePrivate
- Founded2018
- HeadquartersLeek, Netherlands
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What PulmoTech does
PulmoTech BV is a Netherlands-based medical-device developer founded in 2018 in Groningen and headquartered in Leek, building the Intelligent Esophageal Pressure Catheter (iEPC) and broader Intelligent Esophageal Pressure System (iEPS) for adult intensive-care patients on mechanical ventilation. The product combines a solid-state transducer for in-situ, continuous esophageal pressure measurement with nasogastric enteral feeding in a single catheter, addressing the clinical problem that incorrect ventilator settings affect an estimated 20-50% of admitted ICU patients and that current external sensors can only indirectly estimate internal pressures. The device requires no pre-measurement calibration, operates via a one-button zero procedure, and integrates with Philips IntelliVue patient monitors.
The business model is direct B2B enterprise hardware sales to hospital ICUs, with CE MDR approval obtained in January 2024 and ISO 13485:2016 certification in June 2023 enabling European commercial activity. Funding came from Carduso Capital (2019), NV NOM alongside continued Carduso participation (2023), plus regional grants from EFRO-SNN, Gemeente Groningen, and Provincie Groningen. The company employed 1-10 people and was acquired by Sentec effective March 27, 2025, integrating the iEPS into Sentec's respiratory-care portfolio and providing enterprise distribution.
PulmoTech serves a focused clinical niche: intensivists managing mechanically ventilated ICU patients who need individualized ventilation titration. Strategic positioning leveraged clinical advisors including Leo Heunks and operational partners Wellinq Medical (manufacturing), Applied Biosignals (Polybench test software), and Matrix Requirements (QMS tooling). The company's competitive claim rests on combining two previously separate clinical procedures (esophageal pressure measurement and enteral feeding) into one CE-marked device with workflow-friendly ergonomics, though commercial scale, revenue, and installed base remain undisclosed in available materials.
PulmoTech firmographics
Firmographics- Name
- PulmoTech
- Legal name
- PulmoTech BV
- Website
- https://pulmo-tech.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Acquired
- Headcount range
- 1–10 employees
- Short description
- PulmoTech BV develops the CE-marked Intelligent Esophageal Pressure Catheter, a single device that combines in-situ esophageal pressure measurement with nasogastric feeding for adult ICU patients on mechanical ventilation. The Netherlands-based startup was acquired by Sentec in March 2025.
- Ownership category
- akta.pro rank
PulmoTech industry classification
Industry- Product category
- Respiratory Care Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Pulmonary Function Testing (PFT) & Spirometry Equipment (HLAHAGAH)
- akta.pro secondary industry
- Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)
Keywords
Where PulmoTech is headquartered
LocationHeadquarters
- HQ city
- Leek
- HQ country
- Netherlands
- HQ region
- Europe
Offices3 records
Markets served
PulmoTech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Medical device sales: Sale of CE-approved intelligent Esophageal Pressure System (iEPS) and catheters to hospitals and intensive care units. Revenue generated from hardware sales of the combined pressure measurement and enteral feeding catheter system.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
PulmoTech product offering
Product offeringCore offering
PulmoTech develops and manufactures the CE-approved intelligent Esophageal Pressure Catheter (iEPC) and broader Intelligent Esophageal Pressure System (iEPS) for adult ICU patients on mechanical ventilation. The device combines in-situ esophageal pressure measurements via solid-state sensors with nasogastric enteral feeding in a single catheter, enabling intensivists to individualize ventilator settings. The system integrates with Philips IntelliVue patient monitors.
Product overview
PulmoTech offers a unified medical device solution consisting of the Intelligent Esophageal Pressure Catheter (iEPC) and the broader Intelligent Esophageal Pressure System (iEPS). The iEPC is the core catheter product with built-in solid-state sensors, while the iEPS represents the complete measurement system including the catheter, measurement unit, and connectivity to patient monitors. Together, they combine esophageal pressure measurements with enteral feeding in a single device designed for adult intensive care patients on mechanical ventilation.
Differentiator
Problem solved
Functional benefit
Products and services
- Intelligent Esophageal Pressure Catheter (iEPC) A CE-approved catheter that measures esophageal pressure inside the human body using solid-state sensors, providing in-situ and continuous pressure measurements in the same compartment as the lungs. Combines esophageal pressure monitoring with nasogastric enteral feeding delivery in a single device for adult ICU patients on mechanical ventilation.
- Intelligent Esophageal Pressure System (iEPS) The complete system comprising the esophageal pressure catheter combined with the measurement hardware and software, integrating esophageal pressure measurement with a nasogastric feeding catheter. Connects to Philips IntelliVue monitoring systems, offering an enhanced approach to patient monitoring for critically ill ventilated ICU patients.
Quantifiable outcome
- Impact on 20-50% of admitted ICU patients
Companies that use PulmoTech
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles1 record
PulmoTech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature5 records
PulmoTech partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- SenteccoreSentec acquired PulmoTech effective March 27, 2025. The acquisition reinforces Sentec's commitment to advancing respiratory care for compromised patients and aims to reduce challenges faced by respiratory patients, improve healthcare outcomes, and alleviate costs.
- OperationAIRminorPulmoTech partnered with OperationAIR (TU Delft student team) by providing their Michigan Test Lung and Polybench software module to assess emergency ventilator requirements.
- Wellinq MedicalcoreWellinq Medical is a technology partner supporting PulmoTech's development of the esophageal pressure catheter system.
- Applied BiosignalscoreApplied Biosignals is a software partner providing Polybench software integration for testing and assessment of ventilator output using PulmoTech's Michigan Test Lung.
- MD ProjectminorMD Project provides consulting support for medical device development.
- Avania ClinicalminorAvania Clinical provides clinical research and development services.
- TechLeapminorTechLeap.nl provided support through their COVID-19 Access Program including network access and expert sessions.
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
PulmoTech competitors and assessment
Company assessmentDirect peers
- Sentec: Sentec is the strategic acquirer of PulmoTech (effective March 2025) and a specialist in non-invasive respiratory monitoring (e.g., transcutaneous CO2/O2). Directly comparable as an ICU respiratory monitoring company with overlapping clinical customers (ICU, neonatology, sleep labs).
- Philips: Philips provides IntelliVue patient monitoring systems, which is the specific integration platform for PulmoTech's iEPMS. Comparable as the dominant bedside monitoring platform and a current ecosystem partner/dependency.
Broad incumbents
- Hamilton Medical: Hamilton Medical is a leading manufacturer of mechanical ventilators for ICU use. PulmoTech's iEPC is designed as an adjunct to optimize mechanical ventilation; Hamilton's former CSO sits on PulmoTech's strategic advisory bench, evidencing close category adjacency.
- Dräger: Dräger is a global incumbent in ICU ventilation, patient monitoring, and anesthesia. Its integrated ICU platforms compete for the same hospital budgets and clinical workflows that PulmoTech targets.
- Medtronic: Medtronic offers respiratory and patient monitoring solutions (e.g., Nellcor pulse oximetry, INVOS cerebral/somatic oximetry) used in ICU settings alongside mechanical ventilation. Comparable as a multi-modality ICU monitoring incumbent.
- GE HealthCare: GE HealthCare provides ICU patient monitoring (CARESCAPE) and respiratory care solutions. Comparable as an alternative bedside monitor vendor and broader ICU equipment incumbent competing for hospital procurement budgets.
- Mindray: Mindray is a major global vendor of patient monitoring and ICU equipment. Comparable as an alternative bedside monitor vendor and ICU equipment incumbent, particularly relevant for non-Philips European accounts.
Emerging players
- Baxter: Baxter supplies enteral feeding pumps and related disposables used in ICU nutrition. PulmoTech integrates feeding with monitoring, so Baxter is a partial peer via the feeding function and an adjacent vendor in ICU nutrition workflows.
- Vyaire Medical: Vyaire Medical specializes in respiratory diagnostics and ventilation consumables. Comparable as a respiratory-focused player serving ICU and pulmonary function testing markets that overlap with PulmoTech's clinical customers.
- Nihon Kohden: Nihon Kohden provides ICU patient monitoring and neurology solutions. Comparable as an alternative bedside monitoring vendor serving the same ICU clinical workflows targeted by PulmoTech.
Market position
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
PulmoTech social profiles
Digital presencePulmoTech compliance and trust
Trust signalCompliance2 records
PulmoTech financial estimates
Financial estimateRevenue estimate
Valuation estimate
PulmoTech leadership team
Management profileNumber of profiles
Profiles5 records
PulmoTech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PulmoTech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PulmoTech
What does PulmoTech do?
PulmoTech develops and manufactures the CE-approved intelligent Esophageal Pressure Catheter (iEPC) and broader Intelligent Esophageal Pressure System (iEPS) for adult ICU patients on mechanical ventilation. The device combines in-situ esophageal pressure measurements via solid-state sensors with nasogastric enteral feeding in a single catheter, enabling intensivists to individualize ventilator settings. The system integrates with Philips IntelliVue patient monitors.
Is PulmoTech a public or private company?
PulmoTech is a private company. It is classified as corporate owned and is currently acquired.
When was PulmoTech founded?
PulmoTech was founded in 2018. It employs 1 to 10 people.
Where is PulmoTech based?
PulmoTech is headquartered in Leek, Netherlands, in the Europe region.
How does PulmoTech make money?
One revenue line is on record: medical device sales.
Who are PulmoTech's main competitors?
Direct peers on record are Sentec and Philips. Broad incumbents are Hamilton Medical, Dräger, Medtronic, GE HealthCare and Mindray. Emerging players are Baxter, Vyaire Medical and Nihon Kohden.
Does PulmoTech have an API?
No public API is recorded for PulmoTech.
What industry is PulmoTech in?
PulmoTech's product category is Respiratory Care Medical Devices. Its primary akta.pro industry code is HLAHAGAH, Pulmonary Function Testing (PFT) & Spirometry Equipment, with a secondary code of HLAHAGAC, Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home). Its NAICS code is 334510 and its SIC code is 3845.